Abstract

Despite an overall increase in the use of radioactive iodine following total thyroidectomy for primary thyroid cancer, there are still significant variations in use among institutions and across demographically different populations. That variation, however, doesn't appear to have had much of an impact on disease severity, according to a study published online Aug. 16 in JAMA."The recent increase in the incidence of small, low-risk thyroid cancer mandates an understanding of patterns of care in...